Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Hereditary Transthyretin Amyloidosis Research in China
Release Date:
Review Process: Pfizer Internal
Research Rare Disease China
Advances in Immuno-Oncology Therapy in Urothelial Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
RWD in the management of MDR BacteRial severe InfEctions and invasive Fungal disease, ITalian experiences
Release Date:
Review Process: Expert Review Panel
Research Hospital Italy
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Japan, Korea, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, Turkey, United Kingdom
Improving Treatment Environment for Acute Leukemia
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Transthyretin Cardiac Amyloidosis Fellowship - United States
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Applying Patient-Reported Outcomes in Oncology Patient Care Using Quality Improvement and Implementation Science Strategies
Release Date:
Partner: PROTEUS Consortium
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Understanding and Mitigating Cardiovascular Risk in Patients with Prostate Cancer
Release Date:
Partner: NCCN and Myovant
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Cardiac Amyloidosis Mentor mATTch pRogram
Release Date:
Partner: Amyloidosis Foundation
Review Process: Pfizer Internal
Education Rare Disease USA
Knowledge Gaps in Testing, Diagnosis and Treatment of COVID-19
Release Date:
Review Process: Pfizer Internal
Education Hospital USA